Skip to content

MEDICATED AHARA KALPANA IN THE MANAGEMENT OF DYSLIPIDEMIA

CONCEPT OF RUKSHANA UPAKRAMA w.s.r. to TAKRASIDDHA YAVAGU IN THE MANAGEMENT OF DYSLIPIDEMIA

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006581
Enrollment
40
Registered
2016-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Abnormal lipid profile

Interventions

Intervention1: Takrasiddha Yavagu: for 30 days as Ahara ( yavagu will made by 100gm shyamaka and 600ml takra ) at Madhyahana Bhojana Kala (ONE TIME) only Control Intervention1: Takrasiddha Yavagu alon

Sponsors

IPGT RA GAU Jamnagar Gujarat India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between the age group of 18 years to 50 years and diagnosed with abnormal lipid profile will be selected, irrespective of sex, religion etc. from the O.P.D. and I.P.D. of Basic Principles Department, I.P.G.T and R.A. Hospital, G.A.U. Jamnagar.

Exclusion criteria

Exclusion criteria: 1. Patients with age less than 18 years and more than 50 years. 2. Patients suffering from Type 1 and Type 2 Diabetes Mellitus, HTN, CNS disorders. 3. Drug induced Dyslipidemia. 4. Systemic illness like Tuberculosis, Carcinoma, Advanced stage of DM and Endocrine disorders. 5. Patients having features of CCF. 6. Patients having the past history of MI and Unstable Angina.

Design outcomes

Primary

MeasureTime frame
Assessment will be made mainly based on improvement observed in the lipid profile test before and after treatment. All other laboratory investigations conducted before and after treatment will also be considered as assessment criteria. Timepoint: Assessment will be made mainly based on improvement observed in the lipid profile test before and after treatment. All other laboratory investigations conducted before and after treatment will also be considered as assessment criteria.

Secondary

MeasureTime frame
Assessment will be made mainly based on improvement observed in the lipid profile test before and after treatment. All other laboratory investigations conducted before and after treatment will also be considered as assessment criteria. Timepoint: 30 days

Countries

India

Contacts

Public ContactProf Mahesh Vyas

IPGT& and RA GAU Jamnagar

drshubhashre@gmail.com9428400109

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026